Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Oragenics Inc (NYSE MKT LLC:OGEN)

0.55
Delayed Data
As of 3:59pm ET
 +0.04 / +7.84%
Today’s Change
0.50
Today|||52-Week Range
3.87
-63.33%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Revenue and IncomeNet Revenues242.0K329.8K240.2K261.1K
 
 
 
 
 
Cost of Goods Sold68.2K114.5K73.8K71.7K
 
 
 
 
 
Depreciation And Amortization18.6K20.1K18.6K18.3K
 
 
 
 
 
 
Operating ExpensesGross Income155.3K195.2K147.9K171.1K
 
 
 
 
 
General Expenses6.5M2.0M2.3M2.2M
 
 
 
 
 
Research And Development5.6M1.2M1.3M1.2M
 
 
 
 
 
Total Operating Expenses6.6M2.2M2.4M2.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-6.3M-1.8M-2.2M-2.1M
 
 
 
 
 
Interest Expense On Debt10.0K39.6K26.5K771.00
 
 
 
 
 
Other Expenses-900.00380.00-900.000.00
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-6.3M-1.9M-2.2M-2.1M
 
 
 
 
 
Net Income-6.3M-1.9M-2.2M-2.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS36.4M36.4M37.0M40.0M
 
 
 
 
 
Shares To Calculate EPS Diluted36.4M36.4M37.0M40.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.17-$0.05-$0.06-$0.05
 
 
 
 
 
EPS Diluted-$0.17-$0.05-$0.06-$0.05